Plain-English translation of NCT07645443 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The FEEL-GOOD trial is testing a mindfulness-based group therapy program designed specifically for young adults experiencing early psychosis. Over four weeks, participants attend eight group sessions where they learn mindfulness skills, emotion regulation techniques, and strategies for coping with distressing symptoms. The goal is to see whether this therapy, combined with standard psychiatric care, helps reduce symptoms and improves overall wellbeing more than standard care alone.
Early psychosis is a critical window for treatment, and researchers believe that mindfulness and emotion-regulation skills may help young patients better manage symptoms like distressing thoughts and difficult emotions. This trial exists to find out whether this therapy approach can improve outcomes beyond what standard treatment offers.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will first have a screening interview to confirm your diagnosis. Then you'll be randomly assigned to either the mindfulness therapy group plus standard care, or standard care alone. If you receive the therapy, you'll attend one individual preparation session followed by eight group sessions over four weeks (with 4–8 other participants). The sessions cover understanding emotions, mindfulness skills for coping with distressing symptoms, and crisis planning. You'll also have homework and practice exercises. All participants complete assessments at the start, after 4 weeks, and at 6 months to measure any changes in symptoms and wellbeing.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Germany